SaverOne 2014 Ltd.

SVRE
NASDAQScientific & Technical Instruments

-29.0%

since IPO

IPO Price

$5.80

Current Price

$4.12

Return

-29.0%

Market Cap

$3.3M

IPO Date

Jun 3, 2022

Lockup End

Nov 30, 2022

Lockup Status

Lockup expired 1247days ago

Price Performance

Stock price vs IPO price over time (sample data)

Stock Price
IPO Price
Lockup End

Performance Summary

First Day
N/A
1 Month
N/A
3 Months
N/A
6 Months
N/A
1 Year
N/A
Since IPO
-29.0%

SaverOne 2014 Ltd. (SVRE) — IPO Analysis

By Kian O Connor | Updated 4/30/2026

Company Overview

SaverOne 2014 Ltd. (ticker: SVRE) operates in scientific and technical instrument development focused on precision technology and research applications, establishing itself as a notable participant in the scientific instruments sector. Established as a public company and positioned within the evolving market landscape, the company has developed its operations during a period of research automation, precision measurement, and technology advancement and competitive market development. With $3 million in market value, SaverOne 2014 Ltd. focuses on technological innovation, precision capabilities, and application expertise while building stakeholder value through strategic execution and market positioning. The company completed its initial public offering on June 03, 2022, pricing shares at $5.80 each during challenging market conditions with rising rates and growth reassessment. The IPO encountered challenging market conditions, reflecting market assessment of the company's positioning within the scientific instruments sector and growth prospects. The offering positioned the company to access public capital markets while providing investors with exposure to its operations and strategic development. Market reception reflected investor evaluation of technology differentiation, market applications, and customer relationships as key factors in the company's long-term value creation potential. Post-IPO performance has faced significant headwinds, with the stock currently trading at $4.12, representing a decline of -28.97% from the IPO price. This technology adoption and market validation demonstrates substantial investor reassessment in the company's strategic execution within the scientific instruments sector. The market challenges indicate investor evaluation of technology advancement, market application, and customer adoption as critical factors in assessing competitive positioning and sustainable value creation capabilities. Looking ahead, SaverOne 2014 Ltd.'s lockup period expired November 30, 2022. Given the company's positioning within the scientific instruments sector and its performance trajectory since going public, the lockup expiration provided valuable insights into management and early investor confidence in strategic direction. The operational characteristics of companies focused on scientific and technical instrument development focused on precision technology and research applications mean that insider decisions often reflect comprehensive assessments of technology advancement, market application, and customer adoption rather than short-term market fluctuations. The lockup milestone indicates management's confidence in executing strategic objectives and creating sustainable value through technological innovation, precision capabilities, and application expertise within the competitive market landscape.

Performance Overview

Since going public at $5.80 per share on Jun 3, 2022, SaverOne 2014 Ltd. shares have declined 29.0%, disappointing investors who participated in the IPO. The stock currently trades at $4.12, giving the company a market capitalization of $3.3M.

Lockup Expiration

The lockup period for SaverOne 2014 Ltd. expired 1247 days ago on Nov 30, 2022. Insiders and early investors are now free to sell their pre-IPO shares. The post-lockup trading period is often volatile as the market absorbs any additional supply from insider selling.

Industry Context

SaverOne 2014 Ltd. operates in the Scientific & Technical Instruments sector, which has seen varied IPO activity in recent years. The company is headquartered in the United States and is classified under SIC code . Understanding the competitive landscape and sector dynamics is essential for evaluating the long-term prospects of any newly public company in this space. Investors should consider broader market conditions, sector-specific trends, and company fundamentals when assessing SVRE as an investment.

Trading History

SaverOne 2014 Ltd. is actively trading in the public markets with a current share price of $4.12. The company went public at $5.80 per share, representing a decline of 29.0% from the initial offering price. With a current market capitalization of $3.3M, SaverOne 2014 Ltd. continues to establish its presence as a publicly traded entity in the Scientific & Technical Instruments.

Important Disclaimer

This analysis of SaverOne 2014 Ltd. (SVRE) is provided for informational purposes only and should not be construed as investment advice. All data is sourced from SEC EDGAR filings and public market feeds. Past performance is not indicative of future results. Investors should conduct their own due diligence and consult with a qualified financial advisor before making investment decisions. IPOLockup.io is an independent research platform with no financial interest in any of the companies covered.

Insider Selling Activity

Estimated insider trading activity around lockup expiry period (sample data)

3
Pre-Expiry Average
Minimal
88
Expiry Day
Very High
53
Post-Expiry (30d)
High

Activity Heatmap

60 days before/after lockup expiry
Intensity Scale:
Minimal
Low
Moderate
High
Very High
Lockup Expiry

About This Data

This heatmap shows estimated insider selling activity based on typical patterns around lockup expiry periods. Actual data would be derived from SEC Form 4 filings. Higher intensity indicates more insider transactions, which may correlate with increased selling pressure and potential stock price volatility.

Related IPOs

TickerCompanyIndustryIPO DateIPO PriceCurrentReturn
COYACoya Therapeutics, Inc.BiotechnologyDec 29, 2022$5.00$4.26-14.8%
LIPOLipella Pharmaceuticals Inc.BiotechnologyDec 20, 2022$5.75$0.05-99.1%
RAYAErayak Power Solution Group Inc.Electrical Equipment & PartsDec 14, 2022$4.00$3.57-10.8%
JEWLAdamas One Corp.Luxury GoodsDec 9, 2022$4.50$0.00-100.0%
ACRVAcrivon Therapeutics, Inc.BiotechnologyNov 15, 2022$12.50$1.90-84.8%
ATATAtour Lifestyle Holdings LimitedLodgingNov 11, 2022$11.00$37.34+239.4%
ASPIASP Isotopes Inc.ChemicalsNov 10, 2022$4.00$5.24+31.0%
SNALSnail, Inc.Electronic Gaming & MultimediaNov 10, 2022$5.00$0.64-87.2%

Related IPO Analysis

KO
By • Founder & Data Analyst